Case Report
Transient ischaemic attack after spacing the dose of alirocumab: Is it advisable to reduce the doses of PCSK9 inhibitors with very low LDL-cholesterols?
Accidente isquémico transitorio tras espaciar la dosis de alirocumab: ¿es recomendable reducir las dosis de iPCSK9 ante c-LDL muy bajos?
Read
723
Timeswas read the article
228
Total PDF
495
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 12 | 5 | 17 |
| 2025 11 | 52 | 32 | 84 |
| 2025 10 | 31 | 8 | 39 |
| 2025 9 | 30 | 17 | 47 |
| 2025 8 | 20 | 9 | 29 |
| 2025 7 | 16 | 6 | 22 |
| 2025 6 | 15 | 4 | 19 |
| 2025 5 | 19 | 3 | 22 |
| 2025 4 | 6 | 2 | 8 |
| 2025 3 | 13 | 5 | 18 |
| 2025 2 | 13 | 6 | 19 |
| 2025 1 | 12 | 3 | 15 |
| 2024 12 | 11 | 3 | 14 |
| 2024 11 | 13 | 3 | 16 |
| 2024 10 | 5 | 6 | 11 |
| 2024 9 | 8 | 2 | 10 |
| 2024 8 | 9 | 4 | 13 |
| 2024 7 | 9 | 5 | 14 |
| 2024 6 | 5 | 5 | 10 |
| 2024 5 | 6 | 5 | 11 |
| 2024 4 | 8 | 3 | 11 |
| 2024 3 | 11 | 3 | 14 |
| 2024 2 | 6 | 4 | 10 |
| 2024 1 | 7 | 1 | 8 |
| 2023 12 | 5 | 1 | 6 |
| 2023 11 | 5 | 3 | 8 |
| 2023 10 | 5 | 4 | 9 |
| 2023 9 | 5 | 0 | 5 |
| 2023 8 | 7 | 0 | 7 |
| 2023 7 | 5 | 3 | 8 |
| 2023 6 | 3 | 0 | 3 |
| 2023 5 | 5 | 1 | 6 |
| 2023 4 | 6 | 1 | 7 |
| 2023 3 | 4 | 0 | 4 |
| 2023 2 | 8 | 4 | 12 |
| 2023 1 | 11 | 7 | 18 |
| 2022 12 | 6 | 2 | 8 |
| 2022 11 | 8 | 7 | 15 |
| 2022 10 | 8 | 3 | 11 |
| 2022 9 | 12 | 8 | 20 |
| 2022 8 | 7 | 6 | 13 |
| 2022 7 | 6 | 4 | 10 |
| 2022 6 | 7 | 7 | 14 |
| 2022 5 | 9 | 5 | 14 |
| 2022 4 | 10 | 8 | 18 |
| 2022 3 | 13 | 10 | 23 |
| 2022 2 | 3 | 0 | 3 |
Show all